Document is current
Any future updates will be listed below
-
Authors
Kessler, Chiara
Stricker, Hans
Demundo, Daniela
Elzi, Luigia
Monotti, Rita
Bianchi, Giorgia
Llamas, Michael
Spinedi, Luca
Rossi, Davide
Chiesa, Alessandro Felice
Pagnamenta, Alberto
Conti, Marco
Casso, Gabriele
Stoira, Elisa
Valenti, Elisa
Colucci, Giuseppe
Stussi, Georg
Gerber, Bernhard https://orcid.org/0000-0001-5418-0949
Previsdomini, Marco
- License Information
-
More Information
Article History
First Online: 14 August 2020
Compliance with ethical standards
:
: D. Rossi reports grants and personal fees from Abbvie, grants and personal fees from Janssen, grants and personal fees from Gilead, grants and personal fees from AstraZeneca, personal fees from Verastem, personal fees from Loxo, grants from Cellestia, during the conduct of the study; B. Gerber reports grants and personal fees from Pfizer; personal fees and funding for accredited continuing medical education from Sanofi and Alnylam, during the conduct of the study, funding for accredited continuing medical education program from Axonlab, Bayer, Bristol Myers Squibb, Daiichi-Sankyo, Janssen, Mitsubishi Tanabe Pharma, NovoNordisk, Octapharma, Takeda, Sanofi, SOBI; non-financial support from Axonlab and Thermo Fisher from outside the submitted work; All other authors report no conflict of interest related to this study.
: The study was approved by the Ethical Committee Ticino, Switzerland (2020-00838 RIF.CE 3621).
Free to read: This content has been made available to all.
